Full Text View
Tabular View
No Study Results Posted
Related Studies
TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
This study has been completed.
Study NCT00146211   Information provided by Amarin Neuroscience Ltd
First Received: September 2, 2005   Last Updated: December 24, 2007   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Study Completion Date: July 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
No publications provided by Amarin Neuroscience Ltd

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Huntington Study Group TREND-HD Investigators. Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study. Arch Neurol. 2008 Dec;65(12):1582-9.




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services